Highline Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$36.1K Buy
578
+129
+29% +$8.15K 0.01% 314
2026
Q2
$25.9K Sell
449
-60
-12% -$3.44K 0.01% 350
2026
Q1
$30.9K Buy
509
+202
+66% +$11.8K 0.01% 232
2025
Q4
$16.6K Buy
307
+159
+107% +$7.65K ﹤0.01% 291
2025
Q3
$6.68K Sell
148
-20
-12% -$934 ﹤0.01% 503
2025
Q2
$7.79K Sell
168
-226
-57% -$11.1K ﹤0.01% 371
2025
Q1
$24K Buy
394
+95
+32% +$5.54K 0.01% 187
2024
Q4
$16.9K Buy
299
+97
+48% +$5.42K 0.01% 193
2024
Q3
$10.4K Buy
202
+41
+25% +$1.92K ﹤0.01% 249
2024
Q2
$6.7K Buy
161
+11
+7% +$492 ﹤0.01% 258
2024
Q1
$8.14K Hold
150
– – ﹤0.01% 242
2023
Q4
$7.7K Buy
150
+110
+275% +$5.77K ﹤0.01% 224
2023
Q3
$2.32K Hold
40
– – ﹤0.01% 268
2023
Q2
$2.56K Sell
40
-47
-54% -$3.15K ﹤0.01% 216
2023
Q1
$6.03K Buy
87
+47
+118% +$3.32K ﹤0.01% 174
2022
Q4
$2.88K Hold
40
– – ﹤0.01% 199
2022
Q3
$2.84K Buy
+40
New +$2.9K ﹤0.01% 193

Other funds holding BMY

Highline Wealth Partners's BMY Position: Q3 2026 in Review

Highline Wealth Partners increased its Bristol-Myers Squibb (BMY) stake by 29% in Q3 2026, buying an estimated $8.15K and bringing the position to 578 shares worth $36.1K. The position accounts for 0.01% of the portfolio, ranked #314.

Highline Wealth Partners first reported a position in BMY in Q3 2022 and has held it in 17 quarters since. 1,763 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Highline Wealth Partners held 578 shares of Bristol-Myers Squibb worth $36.1K as of Q3 2026.
  • Highline Wealth Partners bought 129 Bristol-Myers Squibb shares in Q3 2026, an estimated $8.15K.
  • Bristol-Myers Squibb made up 0.01% of Highline Wealth Partners's portfolio in Q3 2026, its #314 holding.
  • Highline Wealth Partners first reported a position in Bristol-Myers Squibb in Q3 2022 and has held it in 17 quarters since.
  • 1,763 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Highline Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.